PreciControl Anti-HBc IgM - Hepatitis B virus core immunoglobulin M (IgM) antibody IVD, control
Country: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
Rapport ta 'Valutazzjoni Pubblika
(PAR)
26-05-2019
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Disponibbli minn:
Roche Diagnostics Australia Pty Limited
Klassi:
Class 4
Manifatturat minn:
Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany
Żona terapewtika:
41982 - Hepatitis B virus core immunoglobulin M (IgM) antibody IVD, control
Indikazzjonijiet terapewtiċi:
PreciControl Anti HBc IgM is a ready for use control serum based on human serum both in the negative and positive concentration range. The controls are used for monitoring the accuracy of the Elecsys Anti HBc IgM immunoassay. PreciControl Anti HBc IgM is used for quality control of the Elecsys Anti HBc IgM immunoassay on the Elecsys and cobas e immunoassay analyzers.
L-istatus ta 'awtorizzazzjoni:
A
Data ta 'l-awtorizzazzjoni:
2018-12-07
